Because of the severe phenotypes from RSPO gene knockout studies including embryonic lethality from RSPO3 gene disruption, we generated and used selective monoclonal antibodies against each of three RSPO proteins (RSPO1-3) to test their effects in animal models of fibrosis. This evidence concerns the gene RSPO1 and fibrosis.